Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$255.51 - $362.11 $20,440 - $28,968
-80 Closed
0 $0
Q4 2021

Dec 01, 2022

BUY
$351.38 - $448.68 $28,110 - $35,894
80 New
80 $30,000
Q4 2021

Feb 09, 2022

BUY
$351.38 - $448.68 $28,110 - $35,894
80 New
80 $30,000
Q2 2019

Aug 09, 2019

SELL
$123.4 - $148.55 $31,096 - $37,434
-252 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$104.82 - $146.73 $26,414 - $36,975
252 New
252 $37,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.